adenosine has been researched along with ADPKD in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Knoyle, PM | 1 |
| Aguiari, G; Boletta, A; Bonon, A; de Stephanis, L; Gafà, R; Lanza, G; Pema, M; Pinton, P; Somlo, S; Varani, K | 1 |
| Huang, E; Kasenda, M; Lian, J; Liang, Y; Paterson, AD; Pei, Y; Rogovea, E; Somlo, S; St George-Hyslop, P; Wang, K | 1 |
3 other study(ies) available for adenosine and ADPKD
| Article | Year |
|---|---|
Methionine metabolism: a driver of ADPKD.
Topics: Adenosine; Humans; Methionine; Methyltransferases; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant | 2021 |
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Cell Line; Cell Proliferation; CREB-Binding Protein; Cyclic AMP; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Genetic Predisposition to Disease; Humans; Kidney; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phosphorylation; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; TRPP Cation Channels | 2017 |
A novel frameshift mutation induced by an adenosine insertion in the polycystic kidney disease 2 (PKD2) gene.
Topics: Adenosine; Alleles; Amino Acid Sequence; Base Sequence; Chromosomes, Human, Pair 4; DNA Primers; Exons; Female; Frameshift Mutation; Genetic Linkage; Genotype; Humans; Male; Membrane Proteins; Middle Aged; Models, Molecular; Nucleic Acid Hybridization; Pedigree; Polycystic Kidney, Autosomal Dominant; Polymerase Chain Reaction; Protein Conformation; TRPP Cation Channels | 1998 |